R&D Spending Patterns of Global Firms

R&D spending by the top 320 companies in 2004 was US$ 331 billion. The R&D intensity of these global firms has decreased marginally, as there was a decrease in R&D spending by pharmaceutical firms. R&D spending as a percentage of sales is the highest in the biotechnology industry, fo...

Full description

Saved in:
Bibliographic Details
Published inResearch technology management Vol. 48; no. 5; pp. 51 - 59
Main Authors Bowonder, B., Racherla, J. K., Mastakar, N. V., Krishnan, S.
Format Journal Article
LanguageEnglish
Published Arlington Taylor & Francis 01.09.2005
Industrial Research Institute, Inc
Taylor & Francis Ltd
Subjects
Biotechnology industry
Business innovation
Business structures
Competition
Computer technology
Corporations
distributed innovation
Globalization
Industrial machinery
Industrial research
Industry
Innovations
R&D spending
Research & development expenditures
Spending
Statistical data
Technological innovation
United States > US
Online AccessGet full text

Cover

More Information
Summary:R&D spending by the top 320 companies in 2004 was US$ 331 billion. The R&D intensity of these global firms has decreased marginally, as there was a decrease in R&D spending by pharmaceutical firms. R&D spending as a percentage of sales is the highest in the biotechnology industry, followed by pharmaceuticals and network communications. At the same time, more firms are seeking to acquire intellectual assets from external sources. Managing intellectual assets will require competence to integrate external and internal knowledge assets so that innovation efficiency can go up while idea-to-market time goes down and product pipelines get richer.
ISSN:0895-6308
1930-0166
DOI:10.1080/08956308.2005.11657338